Aytu Biopharma (AYTU) Change in Inventory (2015 - 2026)
Aytu Biopharma's (AYTU) quarterly Change in Inventory came in at -$543000.0 in Q1 2026, down 990.16% year-over-year from $61000.0 in Q1 2025, and up 10.84% quarter-over-quarter from -$609000.0 in Q4 2025.
Analysis
Aytu Biopharma (AYTU) Change in Inventory (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Change in Inventory for 12 consecutive years, with -$543000.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Change in Inventory fell 990.16% year-over-year to -$543000.0 in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 252.25% decrease from a year earlier, with the FY2025 full-year figure at -$382000.0, down 107.92% from the prior year.
- Change in Inventory was -$543000.0 for Q1 2026 at Aytu Biopharma, up from -$609000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $2.1 million in Q3 2022 and troughed at -$1.2 million in Q2 2022.
- A 5-year average of $233705.9 and a median of $79000.0 in 2022 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory surged 1082.02% in 2022 and slumped 990.16% in 2026, its largest moves.
- Over 5 years, Change in Inventory stood at $79000.0 in 2022, then soared by 765.82% to $684000.0 in 2023, then tumbled by 191.67% to -$627000.0 in 2024, then rose by 2.87% to -$609000.0 in 2025, then advanced by 10.84% to -$543000.0 in 2026.
- The last three Change in Inventory figures came in at -$543000.0 (Q1 2026), -$609000.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 443.13 Bn | 436.56 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 365.40 Bn | 358.26 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.79 Bn | 259.10 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.92 Bn | 43.92 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 11.88 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.88 Bn | 683.80 Mn | 17.70 Mn |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | -543,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -543,000.00 |
| Dec 31, 2025 | -609,000.00 |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | 518,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | -627,000.00 |
| Sep 30, 2024 | -334,000.00 |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 684,000.00 |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 622,000.00 |
| Mar 31, 2023 | 804,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | -1.21 Mn |
| Mar 31, 2022 | -659,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 178,000.00 |
| Jun 30, 2021 | -7.18 Mn |